Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 167572, 8 pages
http://dx.doi.org/10.1155/2015/167572
Review Article

Inhibitory Effects of Antimicrobial Peptides on Lipopolysaccharide-Induced Inflammation

1School of Life Science, Liaoning Normal University, Dalian 116081, China
2Liaoning Provincial Key Laboratory of Biotechnology and Drug Discovery, Liaoning Normal University, Dalian 116081, China

Received 15 June 2015; Revised 17 August 2015; Accepted 25 August 2015

Academic Editor: Philipp M. Lepper

Copyright © 2015 Yue Sun and Dejing Shang. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. A. Janeway Jr. and R. Medzhitov, “Introduction: the role of innate immunity in the adaptive immune response,” Seminars in Immunology, vol. 10, no. 5, pp. 349–350, 1998. View at Publisher · View at Google Scholar
  2. K. Murphy, Janeway's Immunobiology, Garland Science, New York, NY, USA, 8th edition, 2011.
  3. H. Breithaupt, “The new antibiotics,” Nature Biotechnology, vol. 17, pp. 1165–1169, 1999. View at Publisher · View at Google Scholar
  4. M. Caroff, D. Karibian, J.-M. Cavaillon, and N. Haeffner-Cavaillon, “Structural and functional analyses of bacterial lipopolysaccharides,” Microbes and Infection, vol. 4, no. 9, pp. 915–926, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. J. J. Gesell, M. Zasloff, and S. J. Opella, “Two-dimensional 1H NMR experiments show that the 23-residue magainin antibiotic peptide is an α-helix in dodecylphosphocholine micelles, sodium dodecylsulfate micelles, and trifluoroethanol/water solution,” Journal of Biomolecular NMR, vol. 9, no. 2, pp. 127–135, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Bauer, K. Schweimer, E. Klüver et al., “Structure determination of human and murine β-defensins reveals structural conservation in the absence of significant sequence similarity,” Protein Science, vol. 10, no. 12, pp. 2470–2479, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Mandard, P. Sodano, H. Labbe et al., “Solution structure of thanatin, a potent bactericidal and fungicidal insect peptide, determined from proton two-dimensional nuclear magnetic resonance data,” European Journal of Biochemistry, vol. 256, no. 2, pp. 404–410, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Rozek, J. S. Powers, C. L. Friedrich, and R. E. Hancock, “Structure-based design of an indolicidin peptide analogue with increased protease stability,” Biochemistry, vol. 42, no. 48, pp. 14130–14138, 2003. View at Publisher · View at Google Scholar
  9. M. Zasloff, “Antimicrobial peptides of multicellular organisms,” Nature, vol. 415, no. 6870, pp. 389–395, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. J. A. Hoffmann, F. C. Kafatos, C. A. Janeway Jr., and R. A. B. Ezekowitz, “Phylogenetic perspectives in innate immunity,” Science, vol. 284, no. 5418, pp. 1313–1318, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Shai, “Mode of action of membrane active antimicrobial peptides,” Peptide Science, vol. 66, no. 4, pp. 236–248, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Matsuzaki, “Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes,” Biochimica et Biophysica Acta: Biomembranes, vol. 1462, no. 1-2, pp. 1–10, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. M. R. Yeaman and N. Y. Yount, “Mechanisms of antimicrobial peptide action and resistance,” Pharmacological Reviews, vol. 55, no. 1, pp. 27–55, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Tossi, L. Sandri, and A. Giangaspero, “Amphipathic, α-helical antimicrobial peptides,” Biopolymers, vol. 55, no. 1, pp. 4–30, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. C. R. H. Raetz and C. Whitfield, “Lipopolysaccharide endotoxins,” Annual Review of Biochemistry, vol. 71, pp. 635–700, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. J. N. Israelachvili, Intermolecular and Surface Forces, Academic Press, London, UK, 3rd edition, 2010.
  17. R. E. Hancock, “Alterations in outer membrane permeability,” Annual Review of Microbiology, vol. 38, pp. 237–264, 1984. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Cohen, “The immunopathogenesis of sepsis,” Nature, vol. 420, no. 6917, pp. 885–891, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. R. E. W. Hancock and M. G. Scott, “The role of antimicrobial peptides in animal defenses,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 16, pp. 8856–8861, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. R. R. Schumann, S. R. Leong, G. W. Flaggs et al., “Structure and function of lipopolysaccharide binding protein,” Science, vol. 249, no. 4975, pp. 1429–1433, 1990. View at Publisher · View at Google Scholar · View at Scopus
  21. S. D. Wright, R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison, “CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein,” Science, vol. 249, no. 4975, pp. 1431–1433, 1990. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Akira, S. Uematsu, and O. Takeuchi, “Pathogen recognition and innate immunity,” Cell, vol. 124, no. 4, pp. 783–801, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. B. P. Scicluna, C. van't Veer, M. Nieuwdorp et al., “Role of tumor necrosis factor-α in the human systemic endotoxin-induced transcriptome,” PLoS ONE, vol. 8, no. 11, Article ID e79051, 2013. View at Publisher · View at Google Scholar
  24. M.-F. Shih, L.-Y. Chen, P.-J. Tsai, and J.-Y. Cherng, “In vitro and in vivo therapeutics of β-thujaplicin on LPS-induced inflammation in macrophages and septic shock in mice,” International Journal of Immunopathology and Pharmacology, vol. 25, no. 1, pp. 39–48, 2012. View at Google Scholar · View at Scopus
  25. R. Ladjouzi, A. Bizzini, F. Lebreton et al., “Analysis of the tolerance of pathogenic enterococci and Staphylococcus aureus to cell wall active antibiotics,” Journal of Antimicrobial Chemotherapy, vol. 68, no. 9, Article ID dkt157, pp. 2083–2091, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Andreu and L. Rivas, “Animal antimicrobial peptides: an overview,” Biopolymers—Peptide Science Section, vol. 47, no. 6, pp. 415–433, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Rivas, J. R. Luque-Ortega, and D. Andreu, “Amphibian antimicrobial peptides and protozoa: lessons from parasites,” Biochimica et Biophysica Acta: Biomembranes, vol. 1788, no. 8, pp. 1570–1581, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. J. Gordon, E. G. Romanowski, and A. M. McDermott, “A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs,” Current Eye Research, vol. 30, no. 7, pp. 505–515, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. E. Guaní-Guerra, T. Santos-Mendoza, S. O. Lugo-Reyes, and L. M. Terán, “Antimicrobial peptides: general overview and clinical implications in human health and disease,” Clinical Immunology, vol. 135, no. 1, pp. 1–11, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. W. Van 'T Hof, E. C. I. Veerman, E. J. Heimerhorst, and A. V. N. Amerongen, “Antimicrobial peptides: properties and applicability,” Biological Chemistry, vol. 382, no. 4, pp. 597–619, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. S. M. Alalwani, J. Sierigk, C. Herr et al., “The antimicrobial peptide LL-37 modulates the inflammatory and host defense response of human neutrophils,” European Journal of Immunology, vol. 40, no. 4, pp. 1118–1126, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Pütsep, G. Carlsson, H. G. Boman, and M. Andersson, “Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study,” The Lancet, vol. 360, no. 9340, pp. 1144–1149, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. P. Y. Ong, T. Ohtake, C. Brandt et al., “Endogenous antimicrobial peptides and skin infections in atopic dermatitis,” The New England Journal of Medicine, vol. 347, no. 15, pp. 1151–1160, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. P. Li, T. Wohland, B. Ho, and J. L. Ding, “Perturbation of lipopolysaccharide (LPS) micelles by Sushi 3 (S3) antimicrobial peptide. The importance of an intermolecular disulfide bond in S3 dimer for binding, disruption, and neutralization of LPS,” The Journal of Biological Chemistry, vol. 279, no. 48, pp. 50150–50156, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Wiese, K. Brandenburg, B. Lindner et al., “Mechanisms of action of the bactericidal/permeability-increasing protein BPI on endotoxin and phospholipid monolayers and aggregates,” Biochemistry, vol. 36, no. 33, pp. 10301–10310, 1997. View at Publisher · View at Google Scholar · View at Scopus
  36. C.-Z. Chen, C.-Y. Ou, R.-H. Wang et al., “The role of bactericidal/permeability-increasing protein in men with chronic obstructive pulmonary disease,” COPD, vol. 9, no. 2, pp. 197–202, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. M. G. Scott, H. Yan, and R. E. W. Hancock, “Biological properties of structurally related α-helical cationic antimicrobial peptides,” Infection and Immunity, vol. 67, no. 4, pp. 2005–2009, 1999. View at Google Scholar
  38. A. Bhunia, P. N. Domadia, J. Torres, K. J. Hallock, A. Ramamoorthy, and S. Bhattacharjya, “NMR structure of pardaxin, a pore-forming antimicrobial peptide, in lipopolysaccharide micelles: mechanism of outer membrane permeabilization,” Journal of Biological Chemistry, vol. 285, no. 6, pp. 3883–3895, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Bhunia, A. Ramamoorthy, and S. Bhattacharjya, “Helical hairpin structure of a potent antimicrobial peptide MSI-594 in lipopolysaccharide micelles by NMR spectroscopy,” Chemistry, vol. 15, no. 9, pp. 2036–2040, 2009. View at Publisher · View at Google Scholar
  40. P. N. Domadia, A. Bhunia, A. Ramamoorthy, and S. Bhattacharjya, “Structure, interactions, and antibacterial activities of MSI-594 derived mutant peptide MSI-594F5A in lipopolysaccharide micelles: role of the helical hairpin conformation in outer-membrane permeabilization,” Journal of the American Chemical Society, vol. 132, no. 51, pp. 18417–18428, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. L. Heinbockel, L. Palacios-Chaves, C. Alexander et al., “Mechanism of Hbγ-35-induced an increase in the activation of the human immune system by endotoxins,” Innate Immunity, vol. 21, no. 3, pp. 305–313, 2015. View at Publisher · View at Google Scholar
  42. Y. Kaconis, I. Kowalski, J. Howe et al., “Biophysical mechanisms of endotoxin neutralization by cationic amphiphilic peptides,” Biophysical Journal, vol. 100, no. 11, pp. 2652–2661, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. X. Chen, J. Howe, J. Andrä et al., “Biophysical analysis of the interaction of granulysin-derived peptides with enterobacterial endotoxins,” Biochimica et Biophysica Acta, vol. 1768, no. 10, pp. 2421–2431, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. Y. Sun, W. Dong, L. Sun, L. Ma, and D. Shang, “Insights into the membrane interaction mechanism and antibacterial properties of chensinin-1b,” Biomaterials, vol. 37, pp. 299–311, 2015. View at Publisher · View at Google Scholar
  45. R. Gopal, J. H. Lee, Y. G. Kim, M.-S. Kim, C. H. Seo, and Y. Park, “Anti-microbial, anti-biofilm activities and cell selectivity of the NRC-16 peptide derived from witch flounder, Glyptocephalus cynoglossus,” Marine Drugs, vol. 11, no. 6, pp. 1836–1852, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. N. S. Tan, M. L. P. Ng, Y. H. Yau, P. K. W. Chong, B. Ho, and J. L. Ding, “Definition of endotoxin binding sites in horseshoe crab factor C recombinant sushi proteins and neutralization of endotoxin by sushi peptides,” The FASEB Journal, vol. 14, no. 12, pp. 1801–1813, 2000. View at Publisher · View at Google Scholar · View at Scopus
  47. Y. H. Nan, J.-K. Bang, B. Jacob, I.-S. Park, and S. Y. Shin, “Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37,” Peptides, vol. 35, no. 2, pp. 239–247, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. J. Howe, J. Andrä, R. Conde et al., “Thermodynamic analysis of the lipopolysaccharide-dependent resistance of Gram-negative bacteria against polymyxin B,” Biophysical Journal, vol. 92, no. 8, pp. 2796–2805, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. Y. Liu, B. Ni, J.-D. Ren et al., “Cyclic Limulus anti-lipopolysaccharide (LPS) factor-derived peptide CLP-19 antagonizes LPS function by blocking binding to LPS binding protein,” Biological and Pharmaceutical Bulletin, vol. 34, no. 11, pp. 1678–1683, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. N. Mookherjee and R. E. W. Hancock, “Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections,” Cellular and Molecular Life Sciences, vol. 64, no. 7-8, pp. 922–933, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. K. Suzuki, T. Murakami, K. Kuwahara-Arai, H. Tamura, K. Hiramatsu, and I. Nagaoka, “Human anti-microbial cathelicidin peptide LL-37 suppresses the LPS-induced apoptosis of endothelial cells,” International Immunology, vol. 23, no. 3, pp. 185–193, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. J. H. Moffatt, M. Harper, A. Mansell et al., “Lipopolysaccharide-deficient Acinetobacter baumannii shows altered signaling through host toll-like receptors and increased susceptibility to the host antimicrobial peptide LL-37,” Infection and Immunity, vol. 81, no. 3, pp. 684–689, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. A. V. Karapetyan, Y. M. Klyachkin, S. Selim et al., “Bioactive lipids and cationic antimicrobial peptides as new potential regulators for trafficking of bone marrow-derived stem cells in patients with acute myocardial infarction,” Stem Cells and Development, vol. 22, no. 11, pp. 1645–1656, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. R. L. Williams, H. Y. Sroussi, K. Leung, and P. T. Marucha, “Antimicrobial decapeptide KSL-W enhances neutrophil chemotaxis and function,” Peptides, vol. 33, no. 1, pp. 1–8, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. M. G. Scott, E. Dullaghan, N. Mookherjee et al., “An anti-infective peptide that selectively modulates the innate immune response,” Nature Biotechnology, vol. 25, no. 4, pp. 465–472, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. H. Y. Lee and Y.-S. Bae, “The anti-infective peptide, innate defense-regulator peptide, stimulates neutrophil chemotaxis via a formyl peptide receptor,” Biochemical and Biophysical Research Communications, vol. 369, no. 2, pp. 573–578, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. F. Niyonsaba, A. Someya, M. Hirata, H. Ogawa, and I. Nagaoka, “Evaluation of the effects of peptide antibiotics human β-defensins-1/-2 and LL-37 on histamine release and prostaglandin D2 production from mast cells,” European Journal of Immunology, vol. 31, no. 4, pp. 1066–1075, 2001. View at Google Scholar · View at Scopus